Physician profile
Daniel Hashemi
NPI 1528626314
$2,230.80
in general payments reported to CMS, 2019-2025
17 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what 85% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $107 · 2022: $204 · 2024: $523 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,919.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $495.55 | 2024-2025 | Auvelity |
| Abbvie INC. | $261.35 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $222.16 | 2022-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $161.86 | 2024-2025 | Fanapt, Hetlioz |
| Takeda Pharmaceuticals U.S.A., INC. | $130.71 | 2024-2025 | Trintellix |
| Ucb, INC. | $116.99 | 2024 | Bimzelx |
| Neurocrine Biosciences, INC. | $115.85 | 2025 | |
| Corium, LLC | $115.54 | 2024-2025 | Azstarys |
| Alkermes, INC. | $113.79 | 2022 | |
| Acadia Pharmaceuticals INC | $106.82 | 2020 | |
| Janssen Pharmaceuticals, INC | $101.75 | 2024-2025 | Spravato |
| E.R. Squibb & Sons, L.L.C. | $72.19 | 2024-2025 | Cobenfy |
| Collegium Pharmaceutical, INC. | $69.67 | 2025 | Jornay Pm |
| Noven Therapeutics, LLC | $59.65 | 2024-2025 | Xelstrym |
| Teva Pharmaceuticals USA, INC. | $46.27 | 2025 | Austedo Xr |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22.37 | 2024 | Rexulti |
| Livanova USA, INC. | $18.28 | 2024 | Vns Therapy Symmetry Model 8103 Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hashemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.